Tempus Announces Collaboration with the Children’s Oncology Group to Expand Access to Genomic Testing for Pediatric Cancer Patients – Tempus

Tempus, a leader in artificial intelligence and precision medicine, today announced a collaboration with the Children’s Oncology Group (COG) – a clinical trials group, supported by the National Cancer Institute (NCI), devoted exclusively to childhood, adolescent and young adult cancer research – to assist with their Pediatric MATCH Screening Trial APEC1621SC (NCT03155620). The Pediatric MATCH ……

Read the full article here

Related Articles